Hot or Nothing
See My Plan
Smiling woman wearing eye patches and a white hair towel in warm

What Is the Difference Between the GLOW and KLOW Peptide Stacks?

GLOW vs KLOW: how ingredients differ, why KPV was added, and what single-ingredient research shows.

Get your plan in 2 minutes

Reviewed by Taylor Anderson, RN

Aesthetic Registered Nurse

Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.

Updated September 9, 2026

Quick answer

KLOW is GLOW (GHK-Cu, BPC-157 and TB-500) with KPV added for anti-inflammatory signaling. GHK-Cu has the most direct skin research, but neither blend has been tested together for skin, recovery or inflammation.

Want your jeans to fit again? See which body options fit you and what they cost.

See My Plan
In this guide

Key takeaways

  • Common listings describe GLOW as 50 mg GHK-Cu with 10 mg each of BPC-157 and TB-500, with KLOW adding 10 mg KPV.
  • BPC-157 recovery signals come mainly from rodent tendon, ligament, muscle and bone injury models, with very limited human data.
  • KPV inflammation signals come from mouse bowel-inflammation models, not from injury-recovery testing in women.

KLOW is GLOW with one added ingredient. Both blends center on GHK-Cu, BPC-157 and TB-500, and KLOW adds KPV for anti-inflammatory signaling. Neither blend has been studied as a blend, so what you can learn comes from research on each ingredient alone. GHK-Cu has the most skin research, BPC-157 recovery signals come mostly from rodents, and KPV inflammation data come from mouse gut studies.

What is different between GLOW and KLOW?

GLOW combines three peptides. GHK-Cu is a copper-binding peptide linked to skin and connective tissue repair, while BPC-157 and TB-500 are studied for tissue repair. KLOW includes that same trio and adds KPV, a three-amino-acid piece (Lys-Pro-Val) from the tail end of alpha-MSH, a natural hormone involved in inflammation signaling (source: blend comparison).

Common listings describe GLOW vials as 50 mg GHK-Cu with 10 mg BPC-157 and 10 mg TB-500, and KLOW as that same base with 10 mg KPV added. The extra ingredient does not change the base. It adds a separate focus on anti-inflammatory signaling.

Have these blends been tested together?

No controlled study has tested GLOW or KLOW as a combined blend. An orthopedic overview notes recovery claims for BPC-157 and TB-500 rest almost entirely on animal models, and a 2025 systematic review of BPC-157 found the human record limited to a small retrospective chart review systematic review.

For recovery, single-ingredient results do not equal combined results. You cannot assume what three or four ingredients do together from what each one did alone.

What has each part shown on its own?

GHK-Cu has the clearest skin signals. Lab, animal and small human topical work link it to more collagen, elastin and supportive gel-like molecules in skin, plus support for dermal fibroblasts, the cells that maintain skin structure (source: GHK-Cu review). Those findings describe skin repair. They did not measure muscle or joint recovery.

BPC-157 points more toward injury models, but mostly in rodents. Preclinical models report better tendon, ligament, muscle and bone healing, while the human record is limited to a small retrospective report of knee-pain relief after joint injection, with no clinical safety data (source: systematic review).

KPV, the part that makes KLOW different, has the narrowest record. In two mouse models of bowel inflammation, treated mice recovered sooner and showed less inflammatory buildup in colon tissue (source: mouse colitis study). Those gut findings in mice do not translate to injury recovery in women.

If faster recovery after training or a nagging injury is what you want, you can walk through your history and goals in the /quiz to see if a Hot or Nothing plan fits.

Ready to make a move?

Answer three questions to see the treatment options that fit your goals.

See My Plan

FAQ

What is the ingredient difference between GLOW and KLOW?

GLOW combines GHK-Cu, BPC-157 and TB-500, while KLOW contains that same trio with KPV added. KPV is a short Lys-Pro-Val piece from alpha-MSH studied for inflammation signaling, so it adds a separate anti-inflammatory focus without changing the base blend.

Have GLOW or KLOW been tested as combined blends?

No controlled study has tested either blend together for skin, recovery or inflammation. That means findings from single ingredients cannot be assumed to show what the three- or four-part combinations do together.

What has GHK-Cu shown on its own?

GHK-Cu has the clearest skin signals, linked to more collagen, elastin and supportive gel-like molecules plus support for dermal fibroblasts in lab, animal and small human topical work. Those findings describe skin repair and did not measure muscle or joint recovery.

What has KPV shown on its own?

KPV has the narrowest record, with earlier recovery and less inflammatory buildup in colon tissue in two mouse models of bowel inflammation. Those gut findings in mice do not translate to injury recovery in women.

Keep reading

Every body guide and treatment
Sources (5)
  1. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. · pubmed.ncbi.nlm.nih.gov · captured September 9, 2026
  2. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. · pubmed.ncbi.nlm.nih.gov · captured September 9, 2026
  3. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease | Inflammatory Bowel Diseases | Oxford Academic · academic.oup.com · captured September 9, 2026
  4. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. · pubmed.ncbi.nlm.nih.gov · captured September 9, 2026
  5. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data · mdpi.com · captured September 9, 2026